肝硬化门静脉高压诊治Baveno Ⅶ共识解读——介入科视角  

Consensus interpretation of Baveno Ⅶ in the diagnosis and treatment of portal hypertension in cirrhosis: perspective of interventional radiology department

作　　者：周粟[1] 袁敏[1] ZHOU Su;YUAN Min(Department of Interventional,Shanghai Public Health Clinical Center,Shanghai,200093,China)

机构地区：[1]上海市公共卫生临床中心介入科,上海200093

出　　处：《中国中西医结合消化杂志》2023年第2期89-93,共5页Chinese Journal of Integrated Traditional and Western Medicine on Digestion

基　　金：上海市卫生健康委员会卫生行业临床研究专项(No:202040333)。

摘　　要：2021年10月召开的BavenoⅦ专家共识会,总结了门静脉高压的主要进展及待解决的问题,介入诊疗是其重要内容,如:肝静脉压力梯度对门静脉高压的评估作用、危险分层指导治疗,经颈静脉肝内门体分流术在急性静脉曲张出血、静脉曲张出血二级预防、复发性腹水以及布加综合征、门静脉血栓等方面的应用。为了更好地规范和推动介入诊疗在门静脉高压诊治的临床及科研领域的应用,该文对其相关重点内容进行解读。The expert consensus meeting of Baveno Ⅶ held in October 2021 summarized the main progress and problems to be solved in portal hypertension, part of which involved interventional diagnosis and treatment. For example, hepatic vein pressure gradient(HVPG) has obvious advantages in the evaluation of portal hypertension, risk stratification guidance treatment and other fields. Transjugular intrahepatic portosystemic shunt(TIPS) plays an important role in acute varicose hemorrhage, secondary prevention of varicose hemorrhage, recurrent ascus, as well as the treatment of Budd-Chiari syndrome and portal thrombosis. In order to better standardize and promote the application of interventional diagnosis and treatment in the clinical and scientific research field of the diagnosis and treatment of portal hypertension, the relevant key contents were interpreted in this paper.

关 键 词：BavenoⅦ共识 肝硬化门静脉高压 介入诊疗 解读 

分 类 号：R575.2[医药卫生—消化系统]